https://shop.carnabio.com/blogs/news/a-story-about-biotin-avidin-affinity-and-how-it-accelerate-small-molecule-drug-discovery 2022-06-09T02:21:57-04:00 weekly https://shop.carnabio.com/blogs/news/residence-time-and-compound-selectivity 2022-06-09T02:22:28-04:00 weekly https://shop.carnabio.com/blogs/news/targeted-protein-degraders 2022-06-09T02:19:07-04:00 weekly https://shop.carnabio.com/blogs/news/the-significance-of-atp-concentration-in-cell-free-and-cell-based-assays 2022-06-09T02:23:00-04:00 weekly https://shop.carnabio.com/blogs/news/carna-newsletter-vol-7-kinase-inhibitors-in-the-fight-against-covid-19 2020-05-21T20:54:28-04:00 weekly https://shop.carnabio.com/blogs/news/kinetic-analysis-of-covalent-and-irreversible-inhibitors 2021-06-08T05:26:36-04:00 weekly https://shop.carnabio.com/blogs/news/drug-resistant-egfr-mutations-in-lung-cancer 2021-07-29T06:50:39-04:00 weekly https://shop.carnabio.com/blogs/news/targeted-degradation-of-non-catalytic-kinases-new-drug-discovery-options 2021-09-09T01:19:25-04:00 weekly https://shop.carnabio.com/blogs/news/carna-tech-note-no-1-production-of-highly-active-protein-kinases-for-drug-discovery-applications 2022-06-09T02:27:12-04:00 weekly https://shop.carnabio.com/blogs/news/carna-tech-note-no-2-the-importance-of-assessing-intrinsic-target-kinase-activity 2022-06-09T02:27:37-04:00 weekly https://shop.carnabio.com/blogs/news/carna-tech-note-no-3-evaluating-kinase-inhibitors-in-binding-assays-using-activated-and-non-activated-biotinylated-kinases 2022-06-09T02:28:05-04:00 weekly https://shop.carnabio.com/blogs/news/recommendations-for-off-target-profiling 2022-06-09T02:47:26-04:00 weekly https://shop.carnabio.com/blogs/news/kinase-inhibitors-as-potential-therapeutic-agents-for-covid-19 2022-06-09T03:04:12-04:00 weekly https://shop.carnabio.com/blogs/news/the-importance-of-understanding-the-activity-of-compounds-on-raf-dimerization-in-braf-inhibitor-drug-discovery 2022-06-09T03:34:30-04:00 weekly https://shop.carnabio.com/blogs/news/the-potential-of-pikfyve-inhibitor-as-a-treatment-of-amyotrophic-lateral-sclerosis-als 2022-09-30T04:02:32-04:00 weekly https://shop.carnabio.com/blogs/news/dgk%CE%B1-and-dgk%CE%B6-are-key-targets-for-cancer-immunotherapy 2022-09-30T04:01:13-04:00 weekly https://shop.carnabio.com/blogs/news/alk-drug-resistant-mutations-challenges-for-the-treatment-of-lung-cancer 2023-04-18T02:17:53-04:00 weekly https://shop.carnabio.com/blogs/news/comparative-biochemical-kinase-profiling-of-vegfr2-inhibitors 2023-08-10T03:50:25-04:00 weekly https://shop.carnabio.com/blogs/news/cancer-treatments-using-inhibitors-of-cdk-a-cell-cycle-regulator 2024-05-20T04:09:57-04:00 weekly https://shop.carnabio.com/blogs/news/development-of-targeted-fgfr2-therapies-in-cholangiocarcinoma-overcoming-adverse-effects-and-acquired-drug-resistance 2025-01-30T23:50:02-05:00 weekly https://shop.carnabio.com/blogs/news/clinical-potential-for-off-target-based-drug-repositioning 2025-01-30T23:46:58-05:00 weekly